LLY
★★☆☆☆ PasstemplateEli Lilly and Company
Healthcare · sector percentile 94
Session move
$1,157.49
Vol 0.95× avg
65/100 quant · tgt $1328.83
RS60 -6.1% vs SPY · ADV$ 2571.4M
session 2026-10-06 · Snapshot — not live tape
Since last scan
2026-10-06 → 2026-10-07
Context only — not a buy/sell signal. Built from scan history and cached news/filings.
Snapshot quote
session 2026-10-06 · scan 2026-10-07 · pushed 10-07 14:02 ET · Regular session (stale)
Show quote fundamentalsHide quote fundamentals
- Last (scan/close)
- $1,157.49
- Previous close
- $1,143.12
- Pushed last
- $1,195.05 (stale) · 10-07 14:02 ET · Regular session
- Session open
- $1,147.15
- Last session range
- $1,139.98 – $1,177.06
- 52-week range
- $780.05 – $1,292.65
- Session volume
- 2,123,390
- Avg volume (20d)
- 2,229,674
- Market cap
- $1.03T
- PE (TTM)
- 38.85
- Forward PE
- 24.32
- Dividend yield
- 0.57%
- 1y target est.
- $1,328.83
- Next earnings
- 2026-10-29
Snapshot quote — last daily session bars and scan fundamentals. Not live bid/ask or intraday quotes.
If you put $1,000.00 in
1y ago
$1,378.71
+38%
5y ago
$5,170.14
+417%
Price path only from cached daily closes (adjusted when available). Not dividends cash, fees, or advice.
Market briefing
Curated digest — not a trade signal. Headlines and links as provided by the producer.
- Prediction: Eli Lilly Could Be One of the Biggest Winners of the Next Decade. Here’s Why.
Eli Lilly just delivered one of the most staggering quarters in Big Pharma history, yet Wall Street is barely reacting. Three catalysts in the next 18 months could either push shares to levels few analysts dare to print or expose the cracks in a very expensive story.
Yahoo · 2026-08-24
- Billionaire Ken Griffin Just Loaded Up on Eli Lilly Stock. Should You?
Griffin's Q2 move is already paying off nicely.
Yahoo · 2026-08-24
- 2 Biotech Stocks Shaping Up for Major Breakouts
Moderna's mRNA cancer vaccine breakthrough with Merck fueled a biotech rally, with the IBB near highs. Eli Lilly and Natera both show strong uptrends and possible breakouts.
Yahoo · 2026-08-24
Price Chart
Daily prices from cache
Loading price history…
AI Analysis
- Bull Thesis — LLY scores 64.98/100 (Pass) with revenue growth at 47.7% and a multi-factor profile supporting the current ranking.
- Risks — Key risks for LLY include valuation compression, sector rotation, and any deterioration in earnings momentum or balance-sheet leverage. Context: cached next earnings 2026-10-29.
- Target Upside — Consensus implied upside is 14.8%. Category 'Pass' suggests monitoring position sizing against the 100-point model thresholds.
Score History
30 days of scans. Daily batch adds the next weekday automatically while the API is running.
- DatePriceChgScoreRating
- 2026-10-07$1,157.49+$14.3765.0Pass
- 2026-10-06$1,143.12+$0.2764.0Pass
- 2026-10-05$1,142.85−$7.0065.1Pass
- 2026-10-02$1,149.85−$7.2364.8Pass
- 2026-10-01$1,157.08−$27.5565.9Pass
- 2026-09-30$1,184.63−$0.1565.5Pass
- 2026-09-29$1,184.78+$1.3264.5Pass
- 2026-09-28$1,183.46+$1.5765.2Pass
- 2026-09-25$1,181.89+$30.9068.3Pass
- 2026-09-24$1,150.99−$19.1568.6Pass
- 2026-09-23$1,170.14+$5.2568.8Pass
- 2026-09-22$1,164.89+$11.9669.0Pass
- 2026-09-21$1,152.93+$0.4969.4Pass
- 2026-09-18$1,152.44+$14.6268.8Pass
- 2026-09-17$1,137.82+$1.7168.3Pass
- 2026-09-16$1,136.11−$2.1767.5Pass
- 2026-09-15$1,138.28+$22.5867.8Pass
- 2026-09-14$1,115.70−$7.3066.1Pass
- 2026-09-11$1,123.00−$1.2167.0Pass
- 2026-09-10$1,124.21+$0.3068.0Pass
- 2026-09-09$1,123.91−$25.4568.0Pass
- 2026-09-08$1,149.36$0.0070.0Pass
- 2026-09-07$1,149.36−$10.2470.0Pass
- 2026-09-04$1,159.60−$0.4870.3Watch
- 2026-09-03$1,160.08+$0.0872.1Watch
- 2026-09-02$1,160.00+$3.2771.8Watch
- 2026-09-01$1,156.73−$17.8872.0Watch
- 2026-08-31$1,174.61−$1.4971.2Watch
- 2026-08-28$1,176.10−$13.3169.6Pass
- 2026-08-27$1,189.41—71.2Watch
Quant Breakdown
Short volume (FINRA)
Off-exchange short sale volume ratio vs recent sessions — not a squeeze forecast.
- Short / total
- 49.7%
- vs 20d (z)
- 0.67
- Short vol
- 438,807
- Status
- ok
Squeeze pressure score
full37/100
- Short leg
- 29
- Call leg
- 60
- Activity
- 2.0
- Call vol share
- 68.6%
- PCR (vol)
- 0.46
- Call OI share
- 56.2%
- ATM IV
- 31.6%
FINRA off-exchange short volume (TRF/ADF consolidated). Not short interest as % of float. Squeeze pressure score (0–100) — free composite of off-exchange short volume and (when available) call-side options activity. Not a probability that a squeeze will occur.
Disclosure score
Rule-based News / Insider / Earnings legs from cached SEC filings — context only, not beat/miss or a buy signal.
No recent SEC filings or earnings calendar inputs in the score window yet.
Disclosure event score — rule-based view of recent SEC filings and earnings calendar. Not a prediction that price will move, and not earnings beat/miss.
Earnings surprise (quant context)
From Yahoo/public fundamentals cached on the last quant scan — not part of the disclosure event score, and not a buy signal. Figure can lag the latest print.
Last reported surprise +0.3%
Filings & events
Recent SEC disclosures and earnings dates — context only, not a trade signal.
- Next earnings
- 2026-10-29yahoo_calendar
- Last earnings
- 2026-08-05yahoo_calendar
- SEC ↗42026-09-22
FORM 4
- SEC ↗42026-09-22
FORM 4
- SEC ↗42026-09-22
FORM 4
- SEC ↗42026-09-22
FORM 4
- SEC ↗42026-09-11
FORM 4
- SEC ↗42026-09-04
FORM 4
- SEC ↗42026-09-04
FORM 4
- SEC ↗42026-08-18
FORM 4
- SEC ↗42026-08-18
FORM 4
- SEC ↗42026-08-18
FORM 4
SEC filings as reported; earnings dates may come from Yahoo calendar. Context only — not investment advice and not a prediction that price will move on a filing or event.